Evolution of Cancer\r
英語版 The benefit of anti-angiogenic therapy in EGFR exon 21 L858Rの詳細情報
The benefit of anti-angiogenic therapy in EGFR exon 21 L858R。L858R emerges as a potential biomarker predicting response。Clonal evolution of NSCLC cancer cells and mechanisms of。ZC3H14 facilitates backsplicing by binding to exon-intron。即購入OK!送料無料!出版社Univ of Tokyo Pr; Illustrated版 (1990/9/1)発売日1990/9/1言語英語ハードカバー288ページISBN-100860084604ISBN-13978-0860084600寸法16.51 x 1.91 x 23.5 cm